BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7907040)

  • 21. Intraepithelial neoplasia of the uterine cervix in the teenager.
    Feldman MJ; Kent DR; Pennington RL
    Cancer; 1978 Apr; 41(4):1405-8. PubMed ID: 639001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1993 Mar; 36(3):289-93. PubMed ID: 8454975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
    Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
    Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of carcinoma cervix: role of Pap smear screening.
    Pradhan P
    Nepal Med Coll J; 2003 Dec; 5(2):82-6. PubMed ID: 15024772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear.
    Burk RD; Kadish AS; Calderin S; Romney SL
    Am J Obstet Gynecol; 1986 May; 154(5):982-9. PubMed ID: 3010725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cervical cancer in Butha Buthe, Lesotho. A study of Papanicolaou (Pap) smears in a previously unscreened community over a one-year period.
    Schneider A; Meinhardt G
    Trop Doct; 1984 Oct; 14(4):170-4. PubMed ID: 6495377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speculoscopy as Pap Smear Adjunct.
    Park CH
    Cancer Res Treat; 2003 Dec; 35(6):541-8. PubMed ID: 26680988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
    Valdini A; Vaccaro C; Pechinsky G; Abernathy V
    J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetic acid visualization of the cervix to detect cervical dysplasia.
    Van Le L; Broekhuizen FF; Janzer-Steele R; Behar M; Samter T
    Obstet Gynecol; 1993 Feb; 81(2):293-5. PubMed ID: 8423967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical Papanicolaou smear in pregnancy.
    Connolly TP; Evans AC
    Clin Med Res; 2005 Feb; 3(1):13-8. PubMed ID: 15962016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
    Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
    Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears.
    Spitzer M; Krumholz BA; Chernys AE; Seltzer V; Lightman AR
    Obstet Gynecol; 1987 May; 69(5):731-5. PubMed ID: 3106869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
    Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for cervicography in the detection of premalignant lesions of the cervix uteri?
    Coibion M; Autier P; Vandam P; Delobelle A; Huet F; Hertens D; Vosse M; Andry M; De Sutter P; Heimann R
    Br J Cancer; 1994 Jul; 70(1):125-8. PubMed ID: 8018522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the atypical squamous cell Papanicolaou smear.
    Maier RC; Schultenover SJ
    Int J Gynecol Pathol; 1986; 5(3):242-8. PubMed ID: 3759323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.